Sign up to save your podcasts
Or
Share Managing Urticaria in Resource-Limited Settings
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Managing Urticaria in Resource-Limited Settings
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticaria in real-world clinical settings with varying access to therapies. Following the UCARE conference in Mumbai, they discuss global collaboration, treatment gaps, and practical approaches in resource-limited environments.
They discuss:
🔹 How does urticaria present alongside common allergic comorbidities?
🔹 What challenges exist in accessing modern therapies in South Africa?
🔹 Why are first-generation antihistamines still used in some settings?
🔹 What role does cyclosporine play when newer treatments are not available?
🔹 How can tools like the CRUSE app improve disease monitoring?
🔹 What insights do registries like CURE provide on global disease patterns?
🔹 What role do infections play as potential triggers of urticaria?
The episode highlights the importance of adapting guidelines to local realities, maintaining strong diagnostic workups, and leveraging global collaboration through Global Allergy and Asthma Excellence Network and UCARE to improve patient care worldwide.
Key Learnings from the Episode:
Urticaria often coexists with other allergic diseases.
Treatment access varies significantly between regions.
First-generation antihistamines are still used where options are limited.
Cyclosporine remains an important accessible treatment.
Digital tools like CRUSE can improve patient monitoring.
UAS and UCT are useful but time-consuming in practice.
Registries like CURE help identify regional differences.
Infections can act as triggers in some patients.
Thorough diagnostic workups remain essential.
Global collaboration supports better patient outcomes.
Chapters:
00:00 Introduction to Urticaria and Allergies
02:37 Insights from the UCARE Conference
05:08 Treatment Options and Challenges
06:26 Patient Communication and Monitoring
09:04 Registry Work and Global Patterns
12:14 Pathomechanisms and Treatment Innovations
15:04 The Importance of Thorough Diagnosis
15:50 Conclusion and Future Collaborations
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Feedback form: ATU: https://forms.office.com/e/m6a2uEdsUH
View all episodes
By UCARE, the Global Allergy and Asthma Excellence Network for UrticariaIn this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticaria in real-world clinical settings with varying access to therapies. Following the UCARE conference in Mumbai, they discuss global collaboration, treatment gaps, and practical approaches in resource-limited environments.
They discuss:
🔹 How does urticaria present alongside common allergic comorbidities?
🔹 What challenges exist in accessing modern therapies in South Africa?
🔹 Why are first-generation antihistamines still used in some settings?
🔹 What role does cyclosporine play when newer treatments are not available?
🔹 How can tools like the CRUSE app improve disease monitoring?
🔹 What insights do registries like CURE provide on global disease patterns?
🔹 What role do infections play as potential triggers of urticaria?
The episode highlights the importance of adapting guidelines to local realities, maintaining strong diagnostic workups, and leveraging global collaboration through Global Allergy and Asthma Excellence Network and UCARE to improve patient care worldwide.
Key Learnings from the Episode:
Urticaria often coexists with other allergic diseases.
Treatment access varies significantly between regions.
First-generation antihistamines are still used where options are limited.
Cyclosporine remains an important accessible treatment.
Digital tools like CRUSE can improve patient monitoring.
UAS and UCT are useful but time-consuming in practice.
Registries like CURE help identify regional differences.
Infections can act as triggers in some patients.
Thorough diagnostic workups remain essential.
Global collaboration supports better patient outcomes.
Chapters:
00:00 Introduction to Urticaria and Allergies
02:37 Insights from the UCARE Conference
05:08 Treatment Options and Challenges
06:26 Patient Communication and Monitoring
09:04 Registry Work and Global Patterns
12:14 Pathomechanisms and Treatment Innovations
15:04 The Importance of Thorough Diagnosis
15:50 Conclusion and Future Collaborations
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Feedback form: ATU: https://forms.office.com/e/m6a2uEdsUH